原创《激素联合伐昔洛韦治疗带状疱疹效果观察评估》：本论文为您写带状疱疹毕业论文范文和职称论文提供相关论文参考文献，可免费下载。
[摘 要] 目的 探讨激素联合伐昔洛韦治疗带状疱疹的临床效果.方法 方便选取2014年8月—2016年8月该院收治的122例带状疱疹患者为观察目标,根据随机数字表法分为两组,即对照组和治疗组,各61例.对照组患者给予伐昔洛韦治疗,观察组患者给予伐昔洛韦联合激素治疗,观察比较两组患者的临床疗效、止疱时间、止痛时间、皮损结痂时间、皮损消失时间及不良反应发生情况.结果 观察组患者治疗总有效率98.4%,止疱时间（2.2±0.9）d,止痛时间（2.0±1.0）d,皮损结痂时间（3.0±1.1）d,皮损消失时间（9.6±3.0）d,同对照组患者的88.5%、（3.2±1.0）d、（4.6±1.5）d、（4.5±1.7）d、（15.8±3.7）d进行比较,差异有统计学意义（P<0.05）.观察组、对照组患者的不良反应发生率（6.6% vs 8.2%）对比差异无统计学意义（P>0.05）.结论 激素联合伐昔洛韦治疗带状疱疹的临床效果确切,安全性高,值得临床全面应用和推广.
[关键词] 带状疱疹；伐昔洛韦；激素；临床疗效
[中图分类号] R752 [文献标识码] A [文章编号] 1674-0742（2017）05（a）-0145-03
[Abstract] Objective To investigate the clinical effect of hormone combined with valaciclovir in the treatment of herpes zoster. Methods 122 cases of herpes zoster patients in our hospital from August 2014 to August 2016 were selected as the observation target, according to the random number table method was divided into two groups, namely, control group and treatment group, each of 61 cases. The control group were treated with valaciclovir treatment, observation group were treated with valaciclovir combined hormone therapy, clinical observation and comparison of two groups of patients with herpes stopping time, pain time, skin scab, skin lesions disappeared time and drug adverse reactions. Results The total efficiency of the observation group 98.4%, the cessation time （2.2±0.9）d, pain time （2.0±1.0）d, skin crusting time （3.0±1.1）d, the lesions disappeared time （9.6±3.0）d, with 88.5% patients in the control group, （3.2±1.0）d, （4.6±1.5）d, （4.5±1.7）d, （15.8±3.7）d were compared, the difference was statistically significant （P<0.05）. There was no significant difference （P>0.05） between the observation group and the control group in the incidence of adverse reactions（6.6% vs 8.2%）. Conclusion The clinical effect of hormone combined with valaciclovir in the treatment of herpes zoster is effective, high safety, worthy of clinical application and promotion of comprehensive.
[Key words] Herpes zoster； Valaciclovir； Hormone； Clinical effect
帶状疱疹是由水痘-带状疱疹病毒导致的,可沿周围神经走行分布,以神经疼痛为典型症状的病毒感染性皮肤病,多见于中老年群体[1].随着年龄的不断增长,带状疱疹发病率逐渐提升,约有50%的患者在皮疹消退后遗留顽固性神经痛,对患者生活和工作造成了极大的影响[2].所以,怎样预防和减少带状疱疹后遗神经痛的发生,减轻患者痛苦,成为了临床治疗的重要所在[3].为此,该文通过对该院2014年8月—2016年8月收治的122例带状疱疹患者的研究,探讨激素联合伐昔洛韦的临床效果,现报道如下.
1 资料和方法
1.1 一般资料
方便选取该院收治的122例带状疱疹患者为观察目标,根据随机数字表法分为两组,即对照组和治疗组,各61例.对照组中,女26例,男35例；年龄41～82岁,平均为（57.6±6.4）岁.治疗组中,女28例,男33例；年龄43～81岁,平均为（56.8±6.6）岁.统计对比两组患者上述资料可知,差异无统计学意义（P>0.05）,可予以比较.
1.2 方法
对照组患者给予盐酸伐昔洛韦（国药准字H20057723）治疗,2次/d,300 mg/次,口服给药,连续治疗10 d.观察组患者给予伐昔洛韦联合激素治疗,伐昔洛韦用法用量同对照组一致,激素选用甲泼尼龙片（国药准字H20020224）,3次/d,8 mg/次,口服给药,连续治疗7 d.
带状疱疹论文参考资料：
结论：激素联合伐昔洛韦治疗带状疱疹效果观察评估为关于本文可作为相关专业带状疱疹论文写作研究的大学硕士与本科毕业论文带状孢疹最有效偏方论文开题报告范文和职称论文参考文献资料。
